Irek Roslon
CEO
SoundCell
SoundCell provides rapid antibiotic susceptibility testing using its MelodyOne platform, which employs graphene-based biosensors to monitor bacterial nanomotion in real time. The technology delivers results at the single‑cell level far faster than conventional culture methods, enabling clinicians to determine antibiotic effectiveness quickly. By accelerating diagnostics, SoundCell helps reduce unnecessary antibiotic use and supports more targeted patient care.
- Biotechnology
- Healthcare Technology
- Medical Devices
Updated 7 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Problem
Conventional methods for determining antibiotic susceptibility in bacterial and yeast infections can be time-consuming, often requiring several days to yield results. This delay can lead to inappropriate antibiotic prescriptions, prolonged patient recovery times, increased hospital stays, and a higher risk of secondary infections and the development of antimicrobial resistance.
Solution
SoundCell offers a rapid diagnostic solution for antibiotic susceptibility testing (AST) at the single-cell level, providing actionable results within one hour. The technology utilizes a graphene-based sensor to monitor the response of individual bacterial or yeast cells to different antibiotics. By directly observing cellular behavior, the platform quickly identifies the most effective treatment options, enabling clinicians to make informed decisions and prescribe targeted therapies. This approach reduces the reliance on broad-spectrum antibiotics, minimizes the risk of resistance development, and improves patient outcomes through faster and more effective treatment.
Target Audience
The primary target audience includes hospitals, clinical laboratories, and healthcare providers seeking to improve the speed and accuracy of antibiotic susceptibility testing for bacterial and yeast infections.
Features
- Graphene-based sensor technology for real-time monitoring of single-cell responses to antibiotics
- Rapid AST results available within one hour, significantly faster than traditional methods
- Single-cell resolution provides detailed insights into antibiotic efficacy and resistance mechanisms
- Direct observation of cellular behavior eliminates the need for lengthy culture-based assays
- Enables targeted antibiotic prescriptions, reducing the use of broad-spectrum antibiotics
- Supports the development of personalized treatment strategies based on individual patient needs